Condition: Bariatric Surgery · Cardiac Surgery With Sternotomy · Post-operative Pain · Sponsor: Icahn School of Medicine at Mount Sinai
This is prospective, randomized study. The purpose of this study is to evaluate whether the addition of Suzetrigine to well established multimodal pain regimen for participants undergoing bariatric patients undergoing weight-loss surgery and cardiac patients undergoing sternotomy will reduce post-operative opioid consumption and pain scores.
This description comes directly from the study's public registry record.
Himani Bhatt, DO · 212-523-2500 · himani.bhatt@mountsinai.org
Michael Lazar, MD · 212-523-2500 · michael.lazar@mountsinai.org
Always discuss trial participation with your own doctor first.
| Mount Sinai Morningside | New York, New York, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07539623